ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2022 American Transplant Congress

    Hold the Opioids Please: Long-Term Outcomes Following an Opioid Minimization Protocol in Kidney Transplantation

    T. Carcella, N. Patel, J. Marable, J. Fleming, P. Baliga, D. Dubay, S. Bethi, D. Taber, V. Rohan

    Medical University of South Carolina, Charleston, SC

    *Purpose: Opioid use following kidney transplantation (KTX) is associated with an increased risk of graft loss and mortality. Opioid minimization strategies and protocols have demonstrated…
  • 2022 American Transplant Congress

    De Novo DSA in the Setting of Stable Allograft Function is a Benign Finding

    R. J. Knight, E. A. Graviss, D. T. Nguyen, T. N. Eagar, S. G. Yi, H. Podder, M. Hobeika, R. McMillan, A. O. Gaber

    Houston Methodist Hospital, Houston, TX

    *Purpose: We sought to determine the long-term outcome of renal allografts that developed de novo DSA (dnDSA) in the setting of stable renal function.*Methods: A…
  • 2022 American Transplant Congress

    Leveraging Single-Cell Signatures in Kidney Transplant Biopsies Uncovers Immunological Heterogeneity Within Rejection Phenotypes

    J. Callemeyn1, B. Lamarthée1, P. Koshy2, T. Debyser3, E. Van Loon1, A. Franken4, T. Van Brussel4, I. Arijs4, D. Lambrechts4, M. Rabant5, A. Senev1, T. Vaulet6, C. Tinel1, M. Naesens1

    1Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium, 2Department of Morphology and Molecular Pathology, University Hospitals Leuven, Leuven, Belgium, 3Faculty of Medicine, KU Leuven, Leuven, Belgium, 4Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium, 5Necker-Enfants Malades Institute, Institut national de la santé et de la recherche médicale (Inserm), Université de Paris, Paris, France, 6ESAT Stadius Center for Dynamical Systems, Signal Processing and Data Analytics, KU Leuven, Leuven, Belgium

    *Purpose: Rejection of the kidney allograft is hallmarked by the accumulation of inflammatory cells within the renal architecture, leading to microvascular or tubulointerstitial inflammation. However,…
  • 2022 American Transplant Congress

    Associated Factors to Physical Inactivity of Kidney Transplant Patients: Subproject of ADHERE Brazil Multicenter Study

    E. S. Sertorio1, F. A. Colugnati1, K. Denhaerynck2, S. De Smet3, J. O. Medina4, M. M. Reboredo5, S. De Geest2, H. Sanders-Pinheiro1, T. ADHERE BRAZIL Study team1

    1Nephrology, Federal University of Juiz de Fora, Juiz de Fora, Brazil, 2Department of Public Health, Institute of Nursing Science, University of Basel, Basel, Switzerland, 3Transplant Research Group, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium, 4Nephrology, Hsopital do Rim, Federal University of São Paulo, São Paulo, Brazil, 5Pneumology, Federal University of Juiz de Fora, Juiz de Fora, Brazil

    *Purpose: Even though regular physical activity is a current recommendation for kidney transplant recipients (KTR), results from ADHERE Brazil study revealed a high prevalence of…
  • 2022 American Transplant Congress

    Favorable Outcomes in Older Recipients Receiving Simultaneous Kidney Pancreas Transplantation

    P. Budhiraja1, H. Me1, J. Ninan2, S. Reddy2, s. S. Misra1, R. Heilman1, H. Khamash1, K. Reddy1, C. Jadloweic1, N. Katariya1, H. Chakkera1

    1Mayo Clinic, Phoenix, AZ, 2Mayo Clinic, Rochester, MN

    *Purpose: Improved therapeutic advances in diabetes mellitus care have resulted in a higher number of older diabetics on dialysis. The majority of centers use an…
  • 2022 American Transplant Congress

    Does a Second Transplant Increase the Risk for CMV Infection? An Evaluation of the Incidence of CMV Viremia in the Previously Transplanted Kidney Recipient

    J. Byrns1, G. Katz-Greenberg2

    1Pharmacy, Duke University Hospital, Durham, NC, 2Medicine, Duke University Medical Center, Durham, NC

    *Purpose: Cytomegalovirus (CMV) viremia is a common complication of kidney transplant recipients (KTR) with significant morbidity/mortality. Patients who receive multiple transplants are potentially at a…
  • 2022 American Transplant Congress

    Antibody-Mediated Kidney Allograft Rejection (ABMR) Monitoring and Intervention Based on ABMR Subtypes – A Step Towards Precision Diagnosis and Management

    A. Rizvi1, S. Hussain2, M. Kueht3, J. Fair3, A. Gamilla-Crudo4, M. Mujtaba4

    1Internal Medicine, Nephrology, University of Texas Medical Branch, Galveston, TX, 2University of Texas Medical Branch, Houston, TX, 3Surgery, University of Texas Medical Branch, Galveston, TX, 4University of Texas Medical Branch, Galveston, TX

    *Purpose: The monitoring of kidney allograft for early detection of antibody mediated rejection (ABMR) and subsequent intervention using traditional clinical parameters has been insufficient due…
  • 2022 American Transplant Congress

    Clinical Outcomes with IR-tac to LCP-tac Conversion in a Kidney Transplant Population

    F. Bartlett1, J. Newman1, T. Sprague1, S. Patel1, N. Rao2, E. Andrade2, V. Rohan2, M. Casey2, D. Dubay1, D. Taber1

    1Pharmacy, Medical University of South Carolina, Charleston, SC, 2Medical University of South Carolina, Charleston, SC

    *Purpose: LCP-Tac is approved for conversion from IR-Tac in kidney transplant patients with a conversion rate of 70-80%. Studies have demonstrated similar efficacy and safety…
  • 2022 American Transplant Congress

    Are Changes in Clinical Practice Reflected in Gene Expression Profiling Scores After Heart Transplantation?

    T. Wolf-Doty1, K. K. Khush2, J. J. Teuteberg2

    1CareDx, Brisbane, CA, 2Stanford University, Stanford, CA

    *Purpose: AlloMap (AM) is a peripheral blood gene expression profiling (GEP) tool used for the assessment of acute cellular rejection in heart transplant recipients (HT).…
  • 2022 American Transplant Congress

    HCK is a Key Regulator for Macrophage Polarization in Kidney Fibrosis

    C. Wei, M. Chen, Z. Sun, Z. Yi, C. He, W. Zhang

    Icahn School of Medicine at Mount Sinai, New York, NY

    *Purpose: Interstitial fibrosis and tubular atrophy (IF/TA) is common histological abnormality in biopsy of kidney transplants. Our previous study from a prospective human kidney transplant…
  • « Previous Page
  • 1
  • …
  • 73
  • 74
  • 75
  • 76
  • 77
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences